← Open Payments lookup

CAITLIN PITECK: Open Payments

NPI 1528749124 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,905 in 71 payments from 29 companies in 2025. Trend: 2023 $685 · 2024 $2,244 · 2025 $1,905

Food & beverage: $1,905
CompanyPaymentsAmount
Novo Nordisk Inc11$217
AstraZeneca Pharmaceuticals LP6$175
GlaxoSmithKline, LLC.6$161
Amgen Inc.2$150
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$145
ViiV Healthcare Company1$138
Exact Sciences Corporation4$112
Lilly USA, LLC4$80
GENZYME CORPORATION2$79
Gilead Sciences, Inc.2$60

Products named: APRETUDE, XIFAXAN, FARXIGA, Cologuard Collection Kit, TRELEGY ELLIPTA, Rybelsus, DUPIXENT, SPRAVATO.

Industry payments across CA — which companies pay providers there.